Double staining of CD31 and the mural marker α-smooth muscle actin (αSMA) revealed that more αSMA+ covered tumor vessels in tumor tissue from metformin treated mice (Figure 6C and 6D). This evidence concerns the gene ACTA1 and neoplasm.